Higher than normal mitochondrial DNA content associated with better outcome in acute promyelocytic leukaemia? Maybe.
Br J Haematol
; 200(2): 126-127, 2023 01.
Article
em En
| MEDLINE
| ID: mdl-36342482
ABSTRACT
Mitochondrial biology may influence the outcome of therapy for acute promyelocytic leukemia if arsenic trioxide is not part of the treatment. Inclusion of arsenic trioxide in the treatment regimen may cancel the adverse impact of certain mitochondrial abnormalities frequently associated with the disease. Commentary on Pereira-Martins et al. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia. Br J Haematol 2023;200170-174.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Arsenicais
/
Leucemia Promielocítica Aguda
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article